Salarius Pharmaceuticals SLRX Stock
Salarius Pharmaceuticals Price Chart
Salarius Pharmaceuticals SLRX Financial and Trading Overview
| Salarius Pharmaceuticals stock price | 0.84 USD |
| Previous Close | 0.65 USD |
| Open | 0.71 USD |
| Bid | 0.51 USD x 200 |
| Ask | 0.87 USD x 200 |
| Day's Range | 0.69 - 0.9 USD |
| 52 Week Range | 0.51 - 44.1 USD |
| Volume | 5.96M USD |
| Avg. Volume | 3.84M USD |
| Market Cap | 4.92M USD |
| Beta (5Y Monthly) | 0.324 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
SLRX Valuation Measures
| Enterprise Value | 114.55K USD |
| Trailing P/E | N/A |
| Forward P/E | -0.09160305 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.18674965 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -0.021 |
Trading Information
Salarius Pharmaceuticals Stock Price History
| Beta (5Y Monthly) | 0.324 |
| 52-Week Change | -97.55% |
| S&P500 52-Week Change | 21.11% |
| 52 Week High | 44.1 USD |
| 52 Week Low | 0.51 USD |
| 50-Day Moving Average | 0.82 USD |
| 200-Day Moving Average | 6.61 USD |
SLRX Share Statistics
| Avg. Volume (3 month) | 3.84M USD |
| Avg. Daily Volume (10-Days) | 13.61M USD |
| Shares Outstanding | 5.86M |
| Float | 5.82M |
| Short Ratio | 0.31 |
| % Held by Insiders | 0.63% |
| % Held by Institutions | 5.21% |
| Shares Short | 184.64K |
| Short % of Float | 3.14% |
| Short % of Shares Outstanding | 3.14% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:12 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2024 |
| Most Recent Quarter (mrq) | September 30, 2025 |
| Next Fiscal Year End | December 31, 2025 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -69.90% |
| Return on Equity (ttm) | -139.55% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -5563679 USD |
| Net Income Avi to Common (ttm) | -5004758 USD |
| Diluted EPS (ttm) | -24.24 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 4.81M USD |
| Total Cash Per Share (mrq) | 0.82 USD |
| Total Debt (mrq) | 0 USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 3.28 |
| Book Value Per Share (mrq) | 4.498 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -4433218 USD |
| Levered Free Cash Flow (ttm) | -2818466 USD |
Profile of Salarius Pharmaceuticals
| Country | United States |
| State | TX |
| City | Houston |
| Address | 2450 Holcombe Blvd. |
| ZIP | 77021 |
| Phone | 713 913 5608 |
| Website | https://www.salariuspharma.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 2 |
Salarius Pharmaceuticals, Inc. focuses on advancing the peptide conjugate therapeutics through its Immediate Peptide/PPMO/P-PROTAC Alpha-helical Conjugate Technology (IMP3ACT) platform that reduces the complexity of drug development and manufacturing. Its IMP3ACT platform leverages machine learning and artificial intelligence tools alongside synthesis techniques to engineer, optimize, and manufacture peptide conjugates targeting various unmet medical needs. The company focuses on building a portfolio of peptide conjugate therapeutics focusing on infectious diseases and oncology. Salarius Pharmaceuticals, Inc. is based in Houston, Texas.
Q&A For Salarius Pharmaceuticals Stock
What is a current SLRX stock price?
Salarius Pharmaceuticals SLRX stock price today per share is 0.84 USD.
How to purchase Salarius Pharmaceuticals stock?
You can buy SLRX shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Salarius Pharmaceuticals?
The stock symbol or ticker of Salarius Pharmaceuticals is SLRX.
Which industry does the Salarius Pharmaceuticals company belong to?
The Salarius Pharmaceuticals industry is Biotechnology.
How many shares does Salarius Pharmaceuticals have in circulation?
The max supply of Salarius Pharmaceuticals shares is 5.86M.
What is Salarius Pharmaceuticals Price to Earnings Ratio (PE Ratio)?
Salarius Pharmaceuticals PE Ratio is 0.00000000 now.
What was Salarius Pharmaceuticals earnings per share over the trailing 12 months (TTM)?
Salarius Pharmaceuticals EPS is 0 USD over the trailing 12 months.
Which sector does the Salarius Pharmaceuticals company belong to?
The Salarius Pharmaceuticals sector is Healthcare.
Salarius Pharmaceuticals SLRX included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| US Tech Composite IXIC | 26853.98 USD — |
-0.89
|
8.32B USD — | 26769.16 USD — | 27130.88 USD — | — - | 8.32B USD — |
| US Tech Capital Market Composite RCMP | 148.96 USD — |
-1.84
|
— — | 148.23 USD — | 151.02 USD — | — - | — — |
| US Tech Health Care IXHC | 1133.51 USD — |
+1.54
|
— — | 1113.35 USD — | 1133.95 USD — | — - | — — |
- {{ link.label }} {{link}}